Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




New Imaging Method Enables Early Detection of Fungal Infections Caused by Aspergillus Fumigatus

By HospiMedica International staff writers
Posted on 16 Aug 2024

Delays in diagnosing fungal infections caused by Aspergillus fumigatus and other fungi can be critical for immunocompromised patients, potentially leading to severe illnesses or even death. More...

To address this, researchers have developed a novel imaging method that allows for the specific detection of Aspergillus fumigatus infections promptly, without the need for invasive procedures.

Many fungi, including Aspergillus, have adapted to environmental conditions, allowing them to utilize alternate energy sources apart from glucose, such as breaking down complex sugars like cellobiose into simple glucose molecules. Unlike most other microbes and human cells, Aspergillus has this unique ability. Researchers from the National Institutes of Health’s (NIH) Clinical Center and the National Heart, Lung, and Blood Institute (NHLBI, Bethesda, MD, USA) have created a radioactive form of cellobiose. This substance, when introduced into the bloodstream, can be visualized in the body using positron emission tomography (PET) imaging.

In this study published in Science Translational Medicine, the team injected mice with fungal infections with radioactive cellobiose ([18F]-Fluorocellobiose, [18F]-FCB) and then performed scans using a PET scanner designed for small animals. The results showed that the mice with fungal infections accumulated radioactivity, whereas those with bacterial infections or non-infectious inflammation did not. Additionally, the researchers found that the radioactive tracer [18F]-FCB can be used to determine if the mice with fungal infections respond to treatment by comparing PET images taken before and after treatment initiation.

Related Links:
NHLBI


Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
Electrode Solution and Skin Prep
Signaspray
Newborn Hearing Screener
ALGO 7i
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.